{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:46:50Z","timestamp":1793962010124,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["DOR2117447\/21"],"award-info":[{"award-number":["DOR2117447\/21"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["DOR2044453\/20"],"award-info":[{"award-number":["DOR2044453\/20"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["DOR1915748\/19"],"award-info":[{"award-number":["DOR1915748\/19"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["DOR1814224\/18"],"award-info":[{"award-number":["DOR1814224\/18"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["BIRD - 183129\/18"],"award-info":[{"award-number":["BIRD - 183129\/18"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["ID. 956544"],"award-info":[{"award-number":["ID. 956544"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["ID. 721613"],"award-info":[{"award-number":["ID. 721613"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57648-2","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T04:24:19Z","timestamp":1742271859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Species differences in opsonization and phagocyte recognition of preclinical poly-2-alkyl-2-oxazoline-coated nanoparticles"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0699-1859","authenticated-orcid":false,"given":"R.","family":"Tavano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Morillas-Becerril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Geffner-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ronzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gervasutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-2733","authenticated-orcid":false,"given":"G.","family":"Arrigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5561-6804","authenticated-orcid":false,"given":"I.","family":"Battisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-1715","authenticated-orcid":false,"given":"M.","family":"Morbidelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0367-6781","authenticated-orcid":false,"given":"P.","family":"Polverino de Laureto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Palazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2104-4531","authenticated-orcid":false,"given":"A.","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schiavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Coin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Romio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5597-8127","authenticated-orcid":false,"given":"F.","family":"Corzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5045-433X","authenticated-orcid":false,"given":"E.","family":"Jim\u00e9nez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3944-0313","authenticated-orcid":false,"given":"M.","family":"Sturlese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bolcato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7514-3802","authenticated-orcid":false,"given":"S.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-926X","authenticated-orcid":false,"given":"S. M.","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-0364","authenticated-orcid":false,"given":"F.","family":"Mancin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-4473","authenticated-orcid":false,"given":"E.","family":"Papini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"57648_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"57648_CR2","doi-asserted-by":"publisher","first-page":"567365","DOI":"10.3389\/fimmu.2020.567365","volume":"11","author":"E Papini","year":"2020","unstructured":"Papini, E., Tavano, R. & Mancin, F. Opsonins and dysopsonins of nanoparticles: facts, concepts, and methodological guidelines. Front. Immunol. 11, 567365 (2020).","journal-title":"Front. Immunol."},{"key":"57648_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010611-134623","volume":"52","author":"SM Moghimi","year":"2012","unstructured":"Moghimi, S. M., Hunter, A. C. & Andresen, T. L. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol. 52, 481\u2013503 (2012).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"57648_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1159\/000339153","volume":"4","author":"SM Moghimi","year":"2012","unstructured":"Moghimi, S. M. et al. Particulate systems for targeting of macrophages: basic and therapeutic concepts. J. Innate Immun. 4, 509\u2013528 (2012).","journal-title":"J. Innate Immun."},{"key":"57648_CR5","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jaci.2017.08.049","volume":"142","author":"L Shen","year":"2018","unstructured":"Shen, L. et al. Protein corona\u2013mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses. J. Allergy Clin. Immunol. 142, 1558\u20131570 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"57648_CR6","doi-asserted-by":"publisher","first-page":"114396","DOI":"10.1016\/j.addr.2022.114396","volume":"188","author":"HB Haroon","year":"2022","unstructured":"Haroon, H. B., Hunter, A. C., Farhangrazi, Z. S. & Moghimi, S. M. A brief history of long circulating nanoparticles. Adv. Drug Deliv. Rev. 188, 114396 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"57648_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","volume":"403","author":"EE West","year":"2024","unstructured":"West, E. E., Woodruff, T., Fremeaux-Bacchi, V. & Kemper, C. Complement in human disease: approved and up-and-coming therapeutics. Lancet 403, 392\u2013405 (2024).","journal-title":"Lancet"},{"key":"57648_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejpb.2023.11.006","volume":"193","author":"HB Haroon","year":"2023","unstructured":"Haroon, H. B. et al. Activation of the complement system by nanoparticles and strategies for complement inhibition. Eur. J. Pharm. Biopharm. 193, 227\u2013240 (2023).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"57648_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12500","volume":"274","author":"D Ricklin","year":"2016","unstructured":"Ricklin, D., Reis, E. S., Mastellos, D. C., Gros, P. & Lambris, J. D. Complement component C3 \u2013 The \u201cSwiss Army Knife\u201d of innate immunity and host defense. Immunol. Rev. 274, 33\u201358 (2016).","journal-title":"Immunol. Rev."},{"key":"57648_CR10","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1021\/acsnano.8b01806","volume":"12","author":"R Tavano","year":"2018","unstructured":"Tavano, R. et al. C1q-mediated complement activation and C3 opsonization trigger recognition of stealth poly(2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes. ACS Nano 12, 5834\u20135847 (2018).","journal-title":"ACS Nano"},{"key":"57648_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41565-023-01514-z","volume":"19","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Nat. Nanotechnol. 19, 246\u2013254 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"57648_CR12","first-page":"14","volume":"125","author":"PJ Norsworthy","year":"2005","unstructured":"Norsworthy, P. J. et al. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. J. Immunol. 125, 14\u201323 (2005).","journal-title":"J. Immunol."},{"key":"57648_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1078\/0171-2985-00149","volume":"205","author":"M Matsushita","year":"2002","unstructured":"Matsushita, M. & Fujita, T. The role of ficolins in innate immunity. Immunobiol. 205, 490\u2013497 (2002).","journal-title":"Immunobiol."},{"key":"57648_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jconrel.2021.08.048","volume":"338","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Complement opsonization of nanoparticles: differences between humans and preclinical species. J. Control. Release 338, 548\u2013556 (2021).","journal-title":"J. Control. Release"},{"key":"57648_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jconrel.2023.02.022","volume":"356","author":"SM Moghimi","year":"2023","unstructured":"Moghimi, S. M. et al. Perspectives on complement and phagocytic cell responses to nanoparticles: from fundamentals to adverse reactions. J. Control. Release 356, 115\u2013129 (2023).","journal-title":"J. Control. Release"},{"key":"57648_CR16","doi-asserted-by":"publisher","first-page":"101479","DOI":"10.1016\/j.nantod.2022.101479","volume":"44","author":"SM Moghimi","year":"2022","unstructured":"Moghimi, S. M. & Simberg, D. Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology. Nano Today 44, 101479 (2022).","journal-title":"Nano Today"},{"key":"57648_CR17","first-page":"31","volume":"10","author":"O Ogunremi","year":"1993","unstructured":"Ogunremi, O., Tabel, H., Kremmer, E. & Wasiliu, M. Differences in the activity of the alternative pathway of complement in BALB\/c and C57Bl\/6 mice. Exp. Clin. Immunogenet. 10, 31\u201337 (1993).","journal-title":"Exp. Clin. Immunogenet."},{"key":"57648_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1084\/jem.160.2.411","volume":"160","author":"A Baba","year":"1984","unstructured":"Baba, A., Fujita, T. & Tamura, N. Sexual dimorphism of the fifth component of mouse complement. J. Exp. Med. 160, 411\u2013419 (1984).","journal-title":"J. Exp. Med."},{"key":"57648_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-1759(89)90088-4","volume":"125","author":"GL Ong","year":"1989","unstructured":"Ong, G. L. & Mattes, M. J. Mouse strains with typical mammalian levels of complement activity. J. Immunol. Method. 125, 147\u2013158 (1989).","journal-title":"J. Immunol. Method."},{"key":"57648_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1021\/bc00030a001","volume":"5","author":"MC Woodle","year":"1994","unstructured":"Woodle, M. C., Engbers, C. M. & Zalipsky, S. New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. Bioconjug. Chem. 5, 493\u2013496 (1994).","journal-title":"Bioconjug. Chem."},{"key":"57648_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/js9504043","volume":"85","author":"S Zalipsky","year":"1996","unstructured":"Zalipsky, S., Hansen, C. B., Oaks, J. M. & Allen, T. M. Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. J. Pharm. Sci. 85, 133\u2013137 (1996).","journal-title":"J. Pharm. Sci."},{"key":"57648_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.eurpolymj.2016.10.041","volume":"88","author":"H Bludau","year":"2017","unstructured":"Bludau, H. et al. POxylation as an alternative stealth coating for biomedical applications. Eur. Polym. J. 88, 679\u2013688 (2017).","journal-title":"Eur. Polym. J."},{"key":"57648_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nnano.2017.47","volume":"12","author":"PP Wibroe","year":"2017","unstructured":"Wibroe, P. P. et al. Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat. Nanotechnol. 12, 589\u2013594 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"57648_CR24","first-page":"L146","volume":"276","author":"JD Brain","year":"1989","unstructured":"Brain, J. D., Molina, R. M., DeCamp, M. M. & Warner, A. E. Pulmonary intravascular macrophages: their contribution to the mononuclear phagocytic system in 13 species. Am. J. Physiol. 276, L146\u2013L154 (1989).","journal-title":"Am. J. Physiol."},{"key":"57648_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/nn901146y","volume":"4","author":"R Kumar","year":"2010","unstructured":"Kumar, R. et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4, 699\u2013708 (2010).","journal-title":"ACS Nano"},{"key":"57648_CR26","doi-asserted-by":"publisher","first-page":"e29424","DOI":"10.1371\/journal.pone.0029424","volume":"7","author":"F Barandeh","year":"2012","unstructured":"Barandeh, F. et al. Organically modified silica nanoparticles are biocompatible and can be targeted to neurons in vivo. PLoS ONE 7, e29424 (2012).","journal-title":"PLoS ONE"},{"key":"57648_CR27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2217\/nnm.10.65","volume":"5","author":"R Tavano","year":"2010","unstructured":"Tavano, R. et al. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine 5, 881\u2013896 (2010).","journal-title":"Nanomedicine"},{"key":"57648_CR28","doi-asserted-by":"publisher","first-page":"7860","DOI":"10.1021\/ja0343095","volume":"125","author":"I Roy","year":"2003","unstructured":"Roy, I. et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc. 125, 7860\u20137865 (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"57648_CR29","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1039\/b921735e","volume":"20","author":"IM Rio-Echevarria","year":"2010","unstructured":"Rio-Echevarria, I. M. et al. Highly PEGylated silica nanoparticles: stealth nanocarriers. J. Mater. Chem. 20, 2780 (2010).","journal-title":"J. Mater. Chem."},{"key":"57648_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/nano10020298","volume":"10","author":"L Morillas-Becerril","year":"2020","unstructured":"Morillas-Becerril, L. et al. Multifunctional, CD44v6-targeted ORMOSIL nanoparticles enhance drugs toxicity in cancer cells. Nanomaterials 10, 298 (2020).","journal-title":"Nanomaterials"},{"key":"57648_CR31","doi-asserted-by":"publisher","first-page":"102163","DOI":"10.1016\/j.nantod.2024.102163","volume":"55","author":"J Fu","year":"2024","unstructured":"Fu, J., Wu, E., Li, G., Wang, B. & Zhan, C. Anti-PEG antibodies: current situation and countermeasures. Nano Today 55, 102163 (2024).","journal-title":"Nano Today"},{"key":"57648_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/jnt5030007","volume":"5","author":"SM Moghimi","year":"2024","unstructured":"Moghimi, S. M. & Simberg, D. Anti-poly(ethylene glycol) (PEG) antibodies: from where are we coming and where are we going. J. Nanotheranostics 5, 99\u2013103 (2024).","journal-title":"J. Nanotheranostics"},{"key":"57648_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.eurpolymj.2016.11.016","volume":"88","author":"B Verbraeken","year":"2017","unstructured":"Verbraeken, B., Monnery, B. D., Lava, K. & Hoogenboom, R. The chemistry of poly(2-oxazoline)s. Eur. Polym. J. 88, 451\u2013469 (2017).","journal-title":"Eur. Polym. J."},{"key":"57648_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.eurpolymj.2016.11.003","volume":"88","author":"G Morgese","year":"2017","unstructured":"Morgese, G. & Benetti, E. M. Polyoxazoline biointerfaces by surface grafting. Eur. Polym. J. 88, 470\u2013485 (2017).","journal-title":"Eur. Polym. J."},{"key":"57648_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.eurpolymj.2016.09.011","volume":"88","author":"P Wilson","year":"2017","unstructured":"Wilson, P., Ke, P. C., Davis, T. P. & Kempe, K. Poly(2-oxazoline)-based micro- and nanoparticles: a review. Eur. Polym. J. 88, 486\u2013515 (2017).","journal-title":"Eur. Polym. J."},{"key":"57648_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1021\/ja107588q","volume":"133","author":"IM Rio-Echevarria","year":"2011","unstructured":"Rio-Echevarria, I. M. et al. Water-soluble peptide-coated nanoparticles: control of the helix structure and enhanced differential binding to immune cells. J. Am. Chem. Soc. 133, 8\u201311 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"57648_CR37","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1039\/c3nr00402c","volume":"5","author":"F Selvestrel","year":"2013","unstructured":"Selvestrel, F. et al. Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems. Nanoscale 5, 6106\u20136116 (2013).","journal-title":"Nanoscale"},{"key":"57648_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nnano.2016.269","volume":"12","author":"F Chen","year":"2017","unstructured":"Chen, F. et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nat. Nanotechnol. 12, 387\u2013393 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"57648_CR39","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/hmg\/ddi173","volume":"14","author":"T Hummelshoj","year":"2005","unstructured":"Hummelshoj, T. et al. Polymorphisms in the FCN2 gene determine serum variation and function of ficolin-2. Hum. Mol. Genet. 14, 1651\u20131658 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"57648_CR40","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.4049\/jimmunol.1900694","volume":"204","author":"I Jarlhelt","year":"2020","unstructured":"Jarlhelt, I. et al. Circulating ficolin-2 and ficolin-3 form heterocomplexes. J. Immunol. 204, 1919\u20131928 (2020).","journal-title":"J. Immunol."},{"key":"57648_CR41","doi-asserted-by":"publisher","first-page":"e28187","DOI":"10.1371\/journal.pone.0028187","volume":"6","author":"T Hummelsh\u00f8j","year":"2011","unstructured":"Hummelsh\u00f8j, T. et al. Allelic lineages of the ficolin genes (FCNs) are passed from ancestral to descendant primates. PLoS ONE 6, e28187 (2011).","journal-title":"PLoS ONE"},{"key":"57648_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/abbi.1998.0957","volume":"360","author":"T Ohashi","year":"1998","unstructured":"Ohashi, T. & Erickson, H. P. Oligomeric structure and tissue distribution of ficolins from mouse, pig and human. Arch. Biochem. Biophys. 360, 223\u2013232 (1998).","journal-title":"Arch. Biochem. Biophys."},{"key":"57648_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.molimm.2019.06.007","volume":"112","author":"C Casals","year":"2019","unstructured":"Casals, C., Garc\u00eda-Fojeda, B. & Minutti, C. M. Soluble defense collagens: sweeping up immune threats. Mol. Immunol. 112, 291\u2013304 (2019).","journal-title":"Mol. Immunol."},{"key":"57648_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.ircmb.2015.01.003","volume":"316","author":"Y Endo","year":"2015","unstructured":"Endo, Y., Matsushita, M. & Fujita, T. New insights into the role of ficolins in the lectin pathway of innate immunity. Int. l Rev. Cell Mol. Biol. 316, 49\u2013110 (2015).","journal-title":"Int. l Rev. Cell Mol. Biol."},{"key":"57648_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102787118","volume":"118","author":"SA Zwarthoff","year":"2021","unstructured":"Zwarthoff, S. A. et al. C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases. Proc. Natl. Acad. Sci. USA 118, e2102787118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57648_CR46","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.4049\/jimmunol.180.4.2329","volume":"180","author":"H Pa\u00efdassi","year":"2008","unstructured":"Pa\u00efdassi, H. et al. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J. Immunol. 180, 2329\u20132338 (2008).","journal-title":"J. Immunol."},{"key":"57648_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/sj.emboj.7601500","volume":"26","author":"V Garlatti","year":"2007","unstructured":"Garlatti, V. et al. Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J. 26, 623\u2013633 (2007).","journal-title":"EMBO J"},{"key":"57648_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000233475","volume":"2","author":"V Garlatti","year":"2010","unstructured":"Garlatti, V. et al. Structural insights into the recognition properties of human ficolins. J. Innate Immun. 2, 17\u201323 (2010).","journal-title":"J. Innate Immun."},{"key":"57648_CR49","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1016\/j.febslet.2014.10.042","volume":"588","author":"E Laffly","year":"2014","unstructured":"Laffly, E. et al. Human ficolin\u20102 recognition versatility extended: an update on the binding of ficolin\u20102 to sulfated\/phosphated carbohydrates. FEBS Lett. 588, 4694\u20134700 (2014).","journal-title":"FEBS Lett"},{"key":"57648_CR50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-3083.2005.01685.x","volume":"62","author":"PD Frederiksen","year":"2005","unstructured":"Frederiksen, P. D., Thiel, S., Larsen, C. B. & Jensenius, J. C. M\u2010ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand. J. Immunol. 62, 462\u2013473 (2005).","journal-title":"Scand. J. Immunol."},{"key":"57648_CR51","doi-asserted-by":"publisher","first-page":"47513","DOI":"10.1074\/jbc.M407161200","volume":"279","author":"A Krarup","year":"2004","unstructured":"Krarup, A., Thiel, S., Hansen, A., Fujita, T. & Jensenius, J. C. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 279, 47513\u201347519 (2004).","journal-title":"J. Biol. Chem."},{"key":"57648_CR52","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1021\/pr500370g","volume":"13","author":"N Rauniyar","year":"2014","unstructured":"Rauniyar, N., Gupta, V., Balch, W. E. & Yates, J. R. Quantitative proteomic profiling reveals differentially regulated proteins in cystic fibrosis cells. J. Proteome Res. 13, 4668\u20134675 (2014).","journal-title":"J. Proteome Res."},{"key":"57648_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1297-9716-44-98","volume":"44","author":"P Ondrackova","year":"2013","unstructured":"Ondrackova, P. et al. Distribution of porcine monocytes in different lymphoid tissues and the lungs during experimental Actinobacillus pleuropneumoniae infection and the role of chemokines. Vet. Res. 44, 98 (2013).","journal-title":"Vet. Res."},{"key":"57648_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/138797","volume":"2012","author":"DC Kilpatrick","year":"2012","unstructured":"Kilpatrick, D. C. & Chalmers, J. D. Human L-ficolin (ficolin-2) and its clinical significance. J. Biomed. Biotechnol. 2012, 1\u201310 (2012).","journal-title":"J. Biomed. Biotechnol."},{"key":"57648_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1078\/0171-2985-00245","volume":"207","author":"AS Brooks","year":"2003","unstructured":"Brooks, A. S., DeLay, J. P. & Hayes, M. A. Characterization of porcine plasma ficolins that bind Actinobacillus pleuropneumoniae serotype 5B. Immunobiol 207, 327\u2013337 (2003).","journal-title":"Immunobiol"},{"key":"57648_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2007.08.001","volume":"77","author":"ND Keirstead","year":"2008","unstructured":"Keirstead, N. D., Lee, C., Yoo, D., Brooks, A. S. & Hayes, M. A. Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro. Antiviral Res. 77, 28\u201338 (2008).","journal-title":"Antiviral Res."},{"key":"57648_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-3083.2007.01915.x","volume":"65","author":"L Munthe-Fog","year":"2007","unstructured":"Munthe-Fog, L. et al. The impact of FCN2 polymorphisms and haplotypes on the ficolin-2 serum levels. Scand. J. Immunol. 65, 383\u2013392 (2007).","journal-title":"Scand. J. Immunol."},{"key":"57648_CR58","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.3390\/ijms21114134","volume":"21","author":"BZ Zsid\u00f3","year":"2020","unstructured":"Zsid\u00f3, B. Z. & Het\u00e9nyi, C. Molecular structure, binding affinity, and biological activity in the epigenome. Int. J. Mol. Sci. 21, 4134 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"57648_CR59","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3389\/fimmu.2019.02176","volume":"10","author":"J Knopf","year":"2019","unstructured":"Knopf, J., Leppkes, M., Schett, G., Hermann, M. & Mu\u00f1oz, L. Aggregated NETs sequester and detoxify extracellular histones. Front. Immunol. 10, 2176 (2019).","journal-title":"Front. Immunol."},{"key":"57648_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/imm.12741","volume":"151","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Ficolin\u2010A\/2, acting as a new regulator of macrophage polarization, mediates the inflammatory response in experimental mouse colitis. Immunology 151, 433\u2013450 (2017).","journal-title":"Immunology"},{"key":"57648_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46770-0","volume":"13","author":"RD Macarie","year":"2023","unstructured":"Macarie, R. D. et al. Ficolin-2 amplifies inflammation in macrophage-smooth muscle cell cross-talk and increases monocyte transmigration by mechanisms involving IL-1\u03b2 and IL-6. Sci. Rep. 13, 19431 (2023).","journal-title":"Sci. Rep."},{"key":"57648_CR62","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1021\/acsnano.6b07847","volume":"11","author":"G Morgese","year":"2017","unstructured":"Morgese, G., Cavalli, E., M\u00fcller, M., Zenobi-Wong, M. & Benetti, E. M. Nanoassemblies of tissue-reactive, polyoxazoline graft-copolymers restore the lubrication properties of degraded cartilage. ACS Nano 11, 2794\u20132804 (2017).","journal-title":"ACS Nano"},{"key":"57648_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24960-6","volume":"12","author":"L-P Wu","year":"2021","unstructured":"Wu, L.-P. et al. Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking. Nat. Commun. 12, 4858 (2021).","journal-title":"Nat. Commun."},{"key":"57648_CR64","doi-asserted-by":"publisher","first-page":"17710","DOI":"10.1039\/C5NR05290D","volume":"7","author":"C Fedeli","year":"2015","unstructured":"Fedeli, C. et al. The functional dissection of the plasma corona of SiO2-NPs spots histidine rich glycoprotein as a major player able to hamper nanoparticle capture by macrophages. Nanoscale 7, 17710\u201317728 (2015).","journal-title":"Nanoscale"},{"key":"57648_CR65","doi-asserted-by":"publisher","first-page":"7541","DOI":"10.1021\/acs.jafc.0c01593","volume":"68","author":"LB Ebinezer","year":"2020","unstructured":"Ebinezer, L. B. et al. Quantitative proteomics of maize roots treated with a protein hydrolysate: a comparative study with transcriptomics highlights the molecular mechanisms responsive to biostimulants. J. Agric. Food Chem. 68, 7541\u20137553 (2020).","journal-title":"J. Agric. Food Chem."},{"key":"57648_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11409-4","volume":"7","author":"G Resmini","year":"2017","unstructured":"Resmini, G. et al. HMGA1 regulates the plasminogen activation system in the secretome of breast cancer cells. Sci. Rep. 7, 11768 (2017).","journal-title":"Sci. Rep."},{"key":"57648_CR67","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones, G., Willett, P., Glen, R. C., Leach, A. R. & Taylor, R. Development and validation of a genetic algorithm for flexible docking 1. J. Mol. Biol. 267, 727\u2013748 (1997).","journal-title":"J. Mol. Biol."},{"key":"57648_CR68","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jcc.10128","volume":"23","author":"A Jakalian","year":"2002","unstructured":"Jakalian, A., Jack, D. B. & Bayly, C. I. Fast, efficient generation of high\u2010quality atomic charges. AM1\u2010BCC model: II. Parameterization and validation. J. Comput. Chem. 23, 1623\u20131641 (2002).","journal-title":"J. Comput. Chem."},{"key":"57648_CR69","unstructured":"Case, D. A. et al. AMBER 2018 (University of California, 2018)."},{"key":"57648_CR70","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput. Chem."},{"key":"57648_CR71","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"57648_CR72","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"57648_CR73","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1063\/1.439486","volume":"72","author":"HC Andersen","year":"1980","unstructured":"Andersen, H. C. Molecular dynamics simulations at constant pressure and\/or temperature. J. Chem. Phys. 72, 2384\u20132393 (1980).","journal-title":"J. Chem. Phys."},{"key":"57648_CR74","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto, S. & Kollman, P. A. Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952\u2013962 (1992).","journal-title":"J. Comput. Chem."},{"key":"57648_CR75","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57648-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:13:27Z","timestamp":1742314407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57648-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57648"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57648-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2642"}}